Ad
related to: Moderna
Search results
Cramer's Lightning Round: 'I'm a believer' in Moderna
CNBC· 1 day ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 6 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo News· 6 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 6 days agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 3 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 6 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...